SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Bruner, L H
Right arrow Articles by Curren, R D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruner, L H
Right arrow Articles by Curren, R D
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Health Statistics
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

An investigation of new toxicity test method performance in validation studies: 2. comparison of three measures of toxicity test performance

L H Bruner

The Gillette Company, Gillette Environment, Health & Safety, Needham, Massachusetts 02914, USA; Gillette Environment, Health & Safety, 37 A Street, Needham, Massachusetts 02914, USA;leon_bruner{at}gillette.com

G J Carr

The Procter & Gamble Company, Miami Valley Laboratories, Cincinnati, Ohio, USA

J W Harbell

R D Curren

Institute for In Vitro Sciences, Gaithersburg, Maryland, USA

An area that requires further research is how best to measure test method performance in validation studies and how to set criteria that should be used to judge the adequacy of this performance. The studies reported here were designed to begin an investigation of these questions. Computer simulations were used to generate data sets similar to those that might be obtained from a large validation study. These data were then analysed using three procedures including determination of the 95% prediction interval (PI), calculation of Pearson's correlation coefficient and calculation of the contingent probability statistics (CPS), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). The results of this work suggest that of the three approaches examined, quantitative measurements with calculation of the 95% PI provide the most information to allow discrimination between the performance of several different NTMs. The results also suggest that dividing data sets into positive and negative toxicity classifications followed by the calculation of CPS leads to considerable information loss. This loss of information may be so significant that it is not possible in certain circumstances to distinguish between NTMs that are adequate and those that are not.

Key Words: correlation • negative predictive value • positive predictive value • prediction interval • prevalence • sensitivity • specificity • toxicity test performance measurement • toxicity test validation • validation

Human & Experimental Toxicology, Vol. 21, No. 6, 313-323 (2002)
DOI: 10.1191/0960327102ht253oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement